US Edition
News from BioMelbourne Network
Information about BioMelbourne Network
Where is BioMelbourne Network located?BioMelbourne Network's WebsiteMedia Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top BioMelbourne Network News
Artificial Intelligence · AuroraThe anonymous gift to Colorado's only academic eye center will boost research into treating and curing the most serious eye diseases while investing in new technology and recruiting top talentSee the Story
Historic $40 Million Gift to CU Anschutz Dept. of Ophthalmology will Fuel Research and New Therapies
74% Center coverage: 8 sources
Australia · AustraliaPosted: 13 June 2025 Radium Capital, Australia’s leader in R&D finance, has announced plans to lend $400 million to Australian innovators over the next 12 months. Radium Capital has deployed more than $900 million to companies undertaking research… The post Radium Capital unleashes $400m war chest for Aussie innovators first appeared on BioMelbourne Network.Read Article
Radium Capital unleashes $400m war chest for Aussie innovators
United States · United StatesPosted: 13 June 2025 Telix Pharmaceuticals Limited announced that its next-generation PSMA-PET imaging agent for prostate cancer, Gozellix® (kit for the preparation of gallium-68 (68Ga) gozetotide injection), had become commercially available nationwide in the United States (U.S.). Kevin… The post Telix Launches New Prostate Cancer Imaging Agent in U.S. first appeared on BioMelbourne Network.Read Article
